Miroculus (formerly Kapplex) delivers assay flexibility and automation capacity in an affordable digital microfluidics platform, which enables seamless workflow integration from novel molecular protocols to data analytics.
Kapplex was acquired by Miroculus Inc. in 2016. In February 2021, Miroculus closed a Series B financing extension bringing the total capital raised in the round to $45 million. bwnews.pr/3s9abDsbwnews.pr/3s9abDs